General Information of Drug Off-Target (DOT) (ID: OT5G79NO)

DOT Name Protein O-glucosyltransferase 2 (POGLUT2)
Synonyms EC 2.4.1.-; Endoplasmic reticulum resident protein 58; ER protein 58; ERp58; KDEL motif-containing protein 1; Protein O-xylosyltransferase POGLUT2; EC 2.4.2.-
Gene Name POGLUT2
Related Disease
Bipolar disorder ( )
UniProt ID
PLGT2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2DI7
EC Number
2.4.1.-; 2.4.2.-
Pfam ID
PF00630 ; PF05686
Sequence
MFGTLLLYCFFLATVPALAETGGERQLSPEKSEIWGPGLKADVVLPARYFYIQAVDTSGN
KFTSSPGEKVFQVKVSAPEEQFTRVGVQVLDRKDGSFIVRYRMYASYKNLKVEIKFQGQH
VAKSPYILKGPVYHENCDCPLQDSAAWLREMNCPETIAQIQRDLAHFPAVDPEKIAVEIP
KRFGQRQSLCHYTLKDNKVYIKTHGEHVGFRIFMDAILLSLTRKVKMPDVELFVNLGDWP
LEKKKSNSNIHPIFSWCGSTDSKDIVMPTYDLTDSVLETMGRVSLDMMSVQANTGPPWES
KNSTAVWRGRDSRKERLELVKLSRKHPELIDAAFTNFFFFKHDENLYGPIVKHISFFDFF
KHKYQINIDGTVAAYRLPYLLVGDSVVLKQDSIYYEHFYNELQPWKHYIPVKSNLSDLLE
KLKWAKDHDEEAKKIAKAGQEFARNNLMGDDIFCYYFKLFQEYANLQVSEPQIREGMKRV
EPQTEDDLFPCTCHRKKTKDEL
Function
Protein glucosyltransferase that catalyzes the transfer of glucose from UDP-glucose to a serine residue within the consensus sequence peptide C-X-N-T-X-G-S-F-X-C. Can also catalyze the transfer of xylose from UDP-xylose but less efficiently. Specifically targets extracellular EGF repeats of proteins such as NOTCH1, NOTCH3, FBN1, FBN2 and LTBP1. May regulate the transport of NOTCH1 and NOTCH3 to the plasma membrane and thereby the Notch signaling pathway.

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bipolar disorder DISAM7J2 Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [2]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [3]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [4]
Doxorubicin DMVP5YE Approved Doxorubicin affects the expression of Protein O-glucosyltransferase 2 (POGLUT2). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [6]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [7]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [8]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [9]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [10]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [11]
KOJIC ACID DMP84CS Investigative KOJIC ACID increases the expression of Protein O-glucosyltransferase 2 (POGLUT2). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 Linkage disequilibrium analysis in the LOC93081-KDELC1-BIVM region on 13q in bipolar disorder.Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):12-7. doi: 10.1002/ajmg.b.30121.
2 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
3 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
4 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
8 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
9 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
12 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.